Laragh Tormey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laragh Tormey has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adriele Prina-Mello
Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity Translational Medicine Institute, Trinity Centre for Health Sciences, Trinity College Dublin, Dublin, Ireland
1 shared publication - Anna Salvati
Department of Nanomedicine & Drug Targeting, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands
1 shared publication - Anthony Davies
Department of Clinical Medicine, Trinity College Dublin, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland
1 shared publication - Bashir M. Mohamed
Department of Histopathology, Trinity College Dublin, Dublin 8, Ireland
1 shared publication - Connla Edwards
Department of clinical medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin8, Ireland
1 shared publication - Dermot Kelleher
Trinity Centre for Health Sciences, St. James’ Hospital, Dublin, Ireland
1 shared publication
Latest Publications
- Open Access
- 1 January 2011
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 9 (1) , 29
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity
Nanomaterials such as SiO2 nanoparticles (SiO2NP) are finding increasing applications in the biomedical and biotechnological fields such as disease diagnostics, imaging, drug delivery, food, cosmetics and biosensors development. Thus, a mechanistic and systematic evaluation of the potential biological and toxic effects of SiO2NP becomes crucial in order to assess their complete safe applicability limits.
- 1 January 2011
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 9 (1) , 29
Open AccessActivation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity
Nanomaterials such as SiO2 nanoparticles (SiO2NP) are finding increasing applications in the biomedical and biotechnological fields such as disease diagnostics, imaging, drug delivery, food, cosmetics and biosensors development. Thus, a mechanistic and systematic evaluation of the potential biological and toxic effects of SiO2NP becomes crucial in order to assess their complete safe applicability limits.